LI vs RGNX · P/E 24, rev $16.06B vs rev $114.4M
Li Auto Inc (LI) versus Regenxbio Inc (RGNX) — a side-by-side from cached financials, not a winner call.
Li Auto Inc (LI) is a auto manufacturers company listed on US. It is led by Xiang Li.
Regenxbio Inc (RGNX) is a biotechnology company listed on US.
Latest reported LI revenue for 2025-12-31 was $16.06B. Net income was $162.9M. Revenue was down 18.8% from 2024-12-31 to 2025-12-31. LI currently screens at market cap $26.62B and trailing P/E 24.2.
Latest reported RGNX revenue for 2026-06-30 was $114.4M. Net income was -$67.3M. RGNX currently screens at market cap $440.4M.
LI currently screens at market cap $26.62B and trailing P/E 24.2. RGNX currently screens at market cap $440.4M.
Not investment advice. Open the LI and RGNX stock pages for the full models.
Not investment advice.